Joanna Moncrieff

Q: What Schools Are Affiliated With Joanna Moncrieff

Joanna Moncrieff is affiliated with the following schools: University College London, Newcastle University

Joanna Moncrieff's AcademicInfluence.com Rankings

Joanna Moncrieff

Biology

#5686

World Rank

#8225

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Joanna Moncrieff Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Joanna Moncrieff is a British psychiatrist and academic. She is Professor of Critical and Social Psychiatry at University College London and a leading figure in the Critical Psychiatry Network. She is a prominent critic of the modern 'psychopharmacological' model of mental disorder and drug treatment, and the role of the pharmaceutical industry. She has written papers, books and blogs on the use and over-use of drug treatment for mental health problems, the mechanism of action of psychiatric drugs, their subjective and psychoactive effects, the history of drug treatment, and the evidence for its benefits and harms. She also writes on the history and politics of psychiatry more generally. Her best known books are The Myth of the Chemical Cure and The Bitterest Pills.

(See a Problem?)

Joanna Moncrieff's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Psychiatry beyond the current paradigm (2012) (419)
Active placebos versus antidepressants for depression. (2004) (360)
A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. (2000) (315)
Efficacy of antidepressants in adults (2005) (301)
The Myth of the Chemical Cure: A Critique of Psychiatric Drug Treatment (2007) (278)
A systematic review of the effects of antipsychotic drugs on brain volume (2010) (259)
Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. (2012) (256)
Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal‐related relapse (2006) (200)
Development of a quality assessment instrument for trials of treatments for depression and neurosis (2001) (171)
The subjective experience of taking antipsychotic medication: a content analysis of Internet data (2009) (130)
Active placebos versus antidepressants for depression (Review) (2004) (128)
Meta-analysis of trials comparing antidepressants with active placebos (1998) (122)
The serotonin theory of depression: a systematic umbrella review of the evidence (2022) (119)
Trends in sickness benefits in Great Britain and the contribution of mental disorders. (2000) (105)
Childhood trauma in bipolar disorder (2014) (102)
Do Antidepressants Cure or Create Abnormal Brain States? (2006) (93)
Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences. (2015) (90)
Rethinking Models of Psychotropic Drug Action (2005) (88)
Lithium: evidence reconsidered (1997) (88)
Sexual Abuse in People with Alcohol Problems (1996) (86)
Psychiatric diagnosis as a political device (2010) (86)
Drop the language of disorder (2012) (83)
A critique of the dopamine hypothesis of schizophrenia and psychosis. (2009) (82)
The Myth of the Chemical Cure (2007) (81)
Lithium Revisited (1995) (79)
Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: A re-examination (2003) (75)
Are antidepressants overrated? A review of methodological problems in antidepressant trials. (2001) (74)
Drugs versus placebo for dysthymia. (2015) (73)
Clinical trials and the response rate illusion. (2007) (71)
De-Medicalizing Misery: Psychiatry, Psychology and the Human Condition (2011) (71)
Psychiatric drug promotion and the politics of neoliberalism (2006) (66)
The Bitterest Pills (2013) (66)
Antipsychotic Maintenance Treatment: Time to Rethink? (2015) (64)
Is ADHD a valid diagnosis in adults? No (2010) (63)
Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem. (2006) (62)
The creation of the concept of an antidepressant: an historical analysis. (2008) (61)
British psychiatry in the 20th century--observations from a psychiatric journal. (2001) (60)
Sexual abuse and the subsequent development of alcohol problems. (1998) (59)
How do psychiatric drugs work? (2009) (58)
Claims for sickness and disability benefits owing to mental disorders in the UK: trends from 1995 to 2014 (2016) (56)
Forty years of lithium treatment. (1998) (55)
The Psychoactive Effects of Psychiatric Medication: The Elephant in the Room (2013) (53)
The psychoactive effects of antidepressants and their association with suicidality. (2011) (50)
De-Medicalizing Misery (2011) (49)
New drug treatments for alcohol problems: a critical appraisal. (1997) (48)
A comparison of drugs versus placebo for the treatment of dysthymia. (2000) (46)
The antidepressant debate. (2002) (45)
Liberatory Psychiatry: Neoliberalism and biopsychiatry: a marriage of convenience (2008) (44)
'They won't do any harm and might do some good': time to think again on the use of antidepressants? (2011) (39)
Recruitment and retention strategies in mental health trials – A systematic review (2018) (39)
The social and cultural construction of psychiatric knowledge: an analysis of NICE guidelines on depression and ADHD (2013) (39)
The least worst option: user experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample (2018) (38)
The social underpinnings of mental distress in the time of COVID-19 – time for urgent action (2020) (37)
Psychiatry and the pharmaceutical industry: Who pays the piper? (2005) (37)
Are Antidepressants as Effective as Claimed? No, They are Not Effective at All (2007) (36)
Annual Research Review: Attention deficit hyperactivity disorder late birthdate effect common in both high and low prescribing international jurisdictions: a systematic review (2018) (36)
An investigation into the precedents of modern drug treatment in psychiatry (1999) (35)
A comparison of antidepressant trials using active and inert placebos (2003) (33)
The Bitterest Pills: The Troubling Story of Antipsychotic Drugs (2013) (33)
SSRI and SNRI withdrawal symptoms reported on an internet forum. (2018) (31)
Schizophrenia: a critical psychiatry perspective (2015) (31)
Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review (2020) (30)
Are we repeating mistakes of the past? A review of the evidence for esketamine (2020) (30)
The medicalisation of “ups and downs”: The marketing of the new bipolar disorder (2014) (30)
The politics of a new Mental Health Act (2003) (28)
Clinical guidelines on antidepressant withdrawal urgently need updating (2019) (26)
The quality of alcohol treatment research: an examination of influential controlled trials and development of a quality rating system. (1998) (26)
Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction) (2019) (25)
Community treatment orders — a bridge too far? (1999) (24)
Magic Bullets for Mental Disorders: The Emergence of the Concept of an “Antipsychotic” Drug (2013) (23)
Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication (2016) (23)
Opium and the people (2016) (22)
Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review (2020) (22)
A Straight Talking Introduction to Psychiatric Drugs (2009) (21)
Carving Nature at its Joints? DSM and the Medicalization of Everyday Life (2011) (21)
Questioning the ‘neuroprotective’ hypothesis: does drug treatment prevent brain damage in early psychosis or schizophrenia? (2011) (19)
Critical analysis of the concept of adult attention-deficit hyperactivity disorder (2011) (19)
Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data (2019) (18)
Against the stream: Antidepressants are not antidepressants – an alternative approach to drug action and implications for the use of antidepressants (2018) (18)
Critical psychiatry: a brief overview (2019) (18)
Antidepressants: misnamed and misrepresented (2015) (17)
Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder (2020) (17)
Co-opting psychiatry: The alliance between academic psychiatry and the pharmaceutical industry (2007) (16)
Diagnosis and drug treatment (2007) (15)
De-Medicalizing Misery II: Society, Politics and the Mental Health Industry (2014) (15)
‘My Universe is here’: Implications for the Future of Academic Libraries from the Results of a Survey of Researchers (2007) (15)
Research synthesis: systematic reviews and meta-analysis (1998) (15)
Research on a ‘drug-centred’ approach to psychiatric drug treatment: assessing the impact of mental and behavioural alterations produced by psychiatric drugs (2017) (15)
What does the latest meta-analysis really tell us about antidepressants? (2018) (14)
Quetiapine immediate release v. placebo for schizophrenia: systematic review, meta-analysis and reappraisal (2015) (14)
Mental health professionals’ views and experiences of antipsychotic reduction and discontinuation (2019) (13)
Supporting antidepressant discontinuation: the development and optimisation of a digital intervention for patients in UK primary care using a theory, evidence and person-based approach (2020) (13)
A critical analysis of recent data on the long-term outcome of antipsychotic treatment (2018) (13)
Persistent adverse effects of antidepressants (2019) (12)
The pharmaceutical industry and disease mongering (2002) (12)
“Because You’re Worth It”: A Discourse Analysis of the Gendered Rhetoric of the ADHD Woman (2015) (11)
Drug-centred psychopharmacology: a non-diagnostic framework for drug treatment† (2015) (11)
Neoliberalism and the politics of psychaitric drug promotion (2006) (10)
Misrepresenting harms in antidepressant trials (2016) (10)
Antidepressants using active placebos. (2001) (10)
Paracetamol Metabolism in African Villagers (1985) (10)
Understanding Psychotropic Drug Action: The Contribution of the Brain-Disabling Theory (2007) (9)
‘Rapid tranquillisation’: an historical perspective on its emergence in the context of the development of antipsychotic medications (2014) (9)
Opinion Piece: The case for establishing a minimal medication alternative for psychosis and schizophrenia (2021) (9)
De-Medicalizing Misery II (2014) (9)
Double blind random bluff. (2003) (8)
The Politics of Psychiatric Drug Treatment (2006) (8)
Contribution of psychiatric disorders to occupation of NHS beds: analysis of Hospital Episode Statistics (2011) (8)
The Myth of the Antidepressant: An Historical Analysis (2011) (8)
The defeat depression campaign and trends in sickness and invalidity benefits for depressive illness (1999) (7)
Depression: why drugs and electricity are not the answer (2022) (7)
A systematic review of the effects of psychiatric medications on social cognition (2021) (7)
The costs incurred by the NHS in England due to the unnecessary prescribing of dependency-forming medications. (2021) (7)
Ideas about mental health in a neoliberal world (2014) (7)
Visual Presentation of Data (1980) (7)
REDUCE (Reviewing long-term antidepressant use by careful monitoring in everyday practice) internet and telephone support to people coming off long-term antidepressants: protocol for a randomised controlled trial (2020) (7)
Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials (2022) (6)
Active placebos in antidepressant trials (1998) (6)
Is the chemical imbalance an ‘urban legend’? An exploration of the status of the serotonin theory of depression in the academic literature (2022) (6)
The Construction of Psychiatric Diagnoses: The Case of Adult ADHD (2014) (6)
PSYCHIATRIC IMPERIALISM: THE MEDICALISATION OF MODERN LIVING (2010) (6)
Medicalising the moral: the case of depression as revealed in internet blogs (2020) (6)
"It Was the Brain Tumor That Done It!": Szasz and Wittgenstein on the Importance of Distinguishing Disease from Behavior and Implications for the Nature of Mental Disorder (2020) (6)
‘Freedom is more important than health’: Thomas Szasz and the problem of paternalism (2014) (5)
An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders (2022) (5)
Antidepressant prescribing and suicide (2003) (5)
History, violence and collective memory: Implications for mental health in Ecuador (2020) (5)
The Nature of Mental Disorder: Disease, Distress, or Personal Tendency? (2015) (5)
Rebuttal: Depression is Not a Brain Disease (2007) (5)
Association between sexual and substance abuse (1994) (5)
Antipyrine Metabolism in African Villagers (1985) (4)
Psychiatry beyond the Current Paradigm References from Downloaded (2012) (4)
Inconclusive Evidence in Support of the Dopamine Hypothesis of Psychosis: Why Neurobiological Research Must Consider Medication Use, Adjust for Important Confounders, Choose Stringent Comparators, and Use Larger Samples (2018) (4)
All is not as it Seems (2013) (4)
“Being Bipolar”: A Qualitative Analysis of the Experience of Bipolar Disorder as Described in Internet Blogs (2017) (4)
Trends in mental health review tribunal and hospital managers’ hearings in north-east London 1997-2007 (2009) (4)
Tapering antipsychotic medication: practical considerations (2021) (3)
Lithium revisited (1996) (3)
The role of trust and hope in antipsychotic medication reviews between GPs and service users a realist review (2021) (3)
How do participants in clinical trials compare with other patients with schizophrenia? (2021) (3)
A Re-examination of the Placebo-Controlled Trials of Lithium Prophylaxis in Manicâ€"DepressiveDisorder (1995) (3)
Drugs versus placebo for dysthymia (Withdrawn Paper. 2015, Art. no. CD001130) (2015) (3)
Response to ‘A Spoonful of Regulation Helps the Medicine Go Down’ (2007) (3)
The Myth of the Antidepressant (2011) (3)
The Pharmaceutical Industry and the Construction of Psychiatric Diagnoses (3)
Network meta-analysis of antidepressants (2018) (3)
Antidepressant prescribing in general practice: A call to action. (2021) (3)
A comment on 'A systematic review of the effects of antipsychotic drugs on brain volume' by Moncrieff & Leo (2010) The authors reply (2010) (3)
Opium and the People: The Prescription Psychopharmaceutical Epidemic in Historical Context (2017) (2)
Long-term effects of antipsychotics (2015) (2)
The myth of the magic antipsychotic. (2008) (2)
Deconstructing psychiatric drug treatment. (2009) (2)
An Alternative Approach to Drug Treatment in Psychiatry (2018) (2)
The Political Economy of the Mental Health System: A Marxist Analysis (2022) (2)
Selective serotonin reuptake inhibitors (2005) (2)
Author's reply (2018) (2)
The antidepressant debate continues - Reply (2002) (2)
What Is Critical Psychiatry? (2018) (2)
Challenges to psychiatry: Antipsychiatry, the user movement and stigma (2012) (2)
Capitalism and psychiatry: applying Marxist critical theory to the mental health industry (2018) (2)
The Psychopharmacologists. A Collection of Interviews by David Healy. D. Healy. Chapman and Hall: London. 1996. (1997) (2)
Esketamine: uncertain safety and efficacy data in depression (2021) (2)
Psychiatrists should oppose community treatment orders (1999) (2)
Community and Public Relations (1980) (2)
Why it is important to discuss what antidepressants do (2022) (1)
Chlorpromazine: The First Wonder Drug (2013) (1)
Miracle cures for modern-day woes: The rise of prescription drug use and psychiatric diagnoses (2013) (1)
Lack of safeguards in response to restrictive public health measures (2020) (1)
Are antipsychotics good or bad for the brain? A comment on Moncrieff & Leo (2010) The authors reply (2010) (1)
What Is to Be Done (2011) (1)
The medicalisation of modern living (1997) (1)
Not in our Brains: On the Complex Relationship Between Biology and Behavior (2020) (1)
Antidepressant prescribing and suicide [2] (multiple letters) (2003) (1)
Reading the Papers (1980) (1)
A systematic review of social functioning outcome measures in schizophrenia with a focus on suitability for intervention research (2022) (1)
Messing about with the brain: a response to commentaries on ‘Depression: why electricity and drugs are not the answer’ (2022) (1)
A Digital Intervention for Primary Care Practitioners to Support Antidepressant Discontinuation (Advisor for Health Professionals): Development Study (2021) (1)
Medicalising the moral: the case of depression as revealed in internet blogs (2020) (1)
Review: discontinuation rates are the same for serotonin specific reuptake inhibitors and newer tricyclic and heterocyclic antidepressants (1998) (1)
hyperactivity disorder Critical analysis of the concept of adult attention-deficit (2011) (1)
Craddock and Mynors-Wallis's assault on thinking. (2014) (1)
The Construction of Psychiatric Diagnoses (2014) (1)
The functions of an asylum: an analysis of male and female admissions to Essex County Asylum in 1904 (2020) (1)
The Construction of the ‘Antidepressant’ (2008) (1)
The antidepressant debate should move on. Author's reply (2003) (1)
Antipsychotics as particular types of sedatives (2019) (1)
A Straight Talking Introduction to Psychiatric Drugs (Straight Talking Introductions) (2009) (1)
The continuing search for the ''elixir of temperance'' (1997) (1)
Biochemical imbalance in the brain - does it exist? (2008) (1)
Financial accounting and library collections : the bottom line (2006) (1)
The subjective experience of taking antipsychotic drugs (2009) (1)
Modernising mental health services. Psychiatrists should oppose community treatment orders. (1999) (1)
Old and New Drug-Induced Problems (2013) (0)
Is the antidepressant era coming to an end (2005) (0)
What Do Neuroleptics Really Do? A Drug-Centred Account (2008) (0)
The Antipsychotic Epidemic (2013) (0)
The psychopharmacologists. A collection of interviews by David Healy - Healy,D (1997) (0)
The Rise of Psychopharmacology and the Story of the CINP. Edited by T. A. Ban, D. Healy and E. Shorter. (Pp. 448.) Animula Publishing House/Collegium Internationale Neuro-Psychopharmacologicum: Budapest. 1998. (2000) (0)
Some progress in UK psychiatry (2008) (0)
Chemical Cosh: Antipsychotics and Chemical Restraint (2013) (0)
Record Keeping and Storage of Information (1980) (0)
Understanding Psychiatric Drugs as Psychoactive Substances (2017) (0)
Protecting physical health in people with mental illness. (2019) (0)
Genetics of human behaviour (1998) (0)
Are we repeating mistakes of the past? A review of the evidence for esketamine – CORRIGENDUM (2021) (0)
The Birth of the Idea of an ‘Antipsychotic’ (2008) (0)
Clinical review overstates genetic case for schizophrenia (1999) (0)
Short communication Clinical trials and the response rate illusion (2007) (0)
The truth about psychiatric drugs (2008) (0)
Author's reply (2004) (0)
disorder The medicalisation of ' ' ups and downs ' ' : The marketing of the new bipolar (2014) (0)
Developing a digital intervention for primary care practitioners to support antidepressant discontinuation (Preprint) (2021) (0)
The Riddle Book (2018) (0)
Cure or Curse: What Are Antipsychotics? (2013) (0)
Author's reply (2002) (0)
Drugs versus placebo for dysthymia (Review) (2015) (0)
Author reply (2022) (0)
Authors' reply (2013) (0)
“Stabilise-reduce, stabilise-reduce”: A survey of the common practices of deprescribing services and recommendations for future services (2023) (0)
Genetics of human behaviour—Reply (1998) (0)
'Audible thoughts' and 'speech defect'. (1996) (0)
Recruitment to a trial of antipsychotic reduction: impact of an acceptability study (2023) (0)
Designing withdrawal support services for antidepressant users: Patients' views on existing services and what they really need. (2023) (0)
Building a House of Cards (2013) (0)
Psychiatry should reduce commercial sponsorship (2017) (0)
Are Neuroleptics Effective and Specific? A Review of the Evidence (2008) (0)
Analysing the efficacy of clozapine - Reply (2004) (0)
Changing the balance of psychosis (2009) (0)
Clozapine Clozapine v. v. conventional antipsychotic drugs conventional antipsychotic drugs for treatment-resistant schizophrenia: for treatment-resistant schizophrenia: (2003) (0)
Pharma and medical education - Some progress in UK psychiatry (2008) (0)
Education and debate Efficacy of antidepressants in adults (2005) (0)
Banking Facilities and Services (1980) (0)
Professional Secretarial Associations (1980) (0)
The two-fold movement in British philosophy of the eighteenth century (0)
The Disease-Centred Model of Drug Action in Psychiatry (2008) (0)
Democratic Drug Treatment: Implications of the Drug-Centred Model (2008) (0)
Dictation and Transcription (1980) (0)
PHARMA AND MEDICAL EDUCATION (2008) (0)
Social and Business Entertaining (1980) (0)
Recruitment and Interviewing (1980) (0)
Building a House of Cards: The Dopamine Theory of Schizophrenia and Drug Action (2013) (0)
Ten books (2016) (0)
S222. A SYSTEMATIC AND METHODOLOGICAL REVIEW OF RECENT SOCIAL FUNCTIONING MEASURES AND APPROACHES (2020) (0)
Preparation of Material for the Printer (1980) (0)
Naturalistic treatment study of depression in general practice. Antidepressants are overrated. (1999) (0)
The past and future of psychiatry and its drugs (2020) (0)
Physical Treatments and the Disease-Centred Model (2008) (0)
The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis (2023) (0)
Looking Where the Light is: Randomised Controlled Trials of Antipsychotics (2013) (0)
[No Title] (1996) (0)
40 years of lithium treatment (letter) (1998) (0)
The Professional Secretary's Handbook (1980) (0)
Cure or Curse (2013) (0)
The Medicalization of âUps and Downsâ (2014) (0)
Sources of Information and Services (1980) (0)
A comparison of opioid prescription trends in England and the United States from 2008 to 2020 (2023) (0)
The genetics of human behaviour-explanation or ideology? (1998) (0)
Response to Lingford-Hughes and Marshall (1998) (0)
24 (Mis)Trust in ‘triangles of care’: informal carers and antipsychotic medication reduction (2021) (0)
A qualitative exploration of family members' perspectives on reducing and discontinuing antipsychotic medication. (2022) (0)
Evidence on the Action of Lithium and ‘Mood Stabilisers’ (2008) (0)
Changing the balance of psychosis treatment (2009) (0)
Antidepressant prescribing and suicide (vol 327, pg 288, 2003) (2003) (0)
Looking Where the Light is (2013) (0)
Melatonin for sleep disorders in children with neurodevelopmental disorders: protocol for a systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials (2022) (0)
Unbalanced appraisal of psychosocial versus antipsychotic literature. (2022) (0)
The antidepressant debate should move on - Reply (2003) (0)
An Alternative Drug-Centred Model of Drug Action (2008) (0)
Analysing the efficacy of clozapine. Author's reply (2004) (0)
Promotion of psychiatric drugs - Reply (2006) (0)
Recent data on the long-term outcome of antipsychotic treatment in first episode psychosis and schizophrenia: a critical perspective (2019) (0)
Misleading information about antipsychotics (2020) (0)
North Yorkshire DL6 JJG (2006) (0)
Later is not necessarily better: limitations of survival analysis in studies of long-term drug treatment of psychiatric conditions (2021) (0)
Pharmacotherapy in alcohol dependence: The need for consensus on the quality of clinical trials (1998) (0)
The Patientâs Dilemma (2013) (0)
The Arrival of the New Drugs and the Influence of Interest Groups (2008) (0)
The Phoenix Rises: From Tardive Dyskinesia to the Introduction of the ‘Atypicals’ (2013) (0)
Philosophy of Psychopharmacology (2010) (0)
The Phoenix Rises (2013) (0)
The Idea of Special Drugs for Manic Depression (Bipolar Disorder) (2008) (0)
‘A landmark in psychiatric progress’? The role of evidence in the rise and fall of insulin coma therapy (2021) (0)
The Patient’s Dilemma: Other Evidence on the Effects of Antipsychotics (2013) (0)
Active placebos in antidepressant trials [7] (1998) (0)
People accessing antidepressant withdrawal websites report experiencing protracted withdrawal symptoms. There are some differences in the characteristics of withdrawal associated with different classes of antidepressants. Keywords: Antidepressant, SSRI, SNRI, Antidepressant withdrawal, Online report (2018) (0)
The Antipsychotic Epidemic: Prescribing in the Twenty-First Century (2013) (0)
WITHDRAWN: Drugs versus placebo for dysthymia. (2015) (0)
Value and Freedom A review of P.M.S. Hacker’s The Moral Powers: A Study of Human Nature (volume 4). John Wiley & Sons, 2021 (2022) (0)
Maintenance antipsychotic trials and the effect of withdrawal (2022) (0)
What Do Antidepressants Really Do (2008) (0)
Is There Such a Thing as an ‘Antidepressant’? A Review of the Evidence (2008) (0)
Psychiatry and Controversy (2018) (0)
Lithium revisited (letter) (1996) (0)
Title The Psychoactive Effects of Psychiatric Medication : The Elephant in the Room Permalink (2014) (0)
Some progress in UK psychiatry (letter) (2008) (0)
New paradigm: developmental psychopathology Reply (2013) (0)
A Digital Intervention for Primary Care Practitioners to Support Antidepressant Discontinuation (Advisor for Health Professionals): Development Study (Preprint) (2021) (0)
Challenging conventional models of psychiatric drug therapy: an alternative patient-centered approach (2010) (0)
Promotion of psychiatric drugs. Author's reply (2006) (0)
Evidence does not confirm that lithium prevents suicide: a reply to Bschor et al. (2022) (0)
Magic Bullets: The Development of Ideas on Drug Action (2013) (0)
placebosof trials comparing antidepressants with active (2011) (0)
The First Tentacles: The ‘Early Intervention in Psychosis’ Movement (2013) (0)
The First Tentacles (2013) (0)
The Role of Trust and Hope in Antipsychotic Medication Reviews in Primary Care Settings: A Realist Review. (2021) (0)
Prescriptions for the Mind: A Critical View of Contemporary Psychiatry (2009) (0)
Modern Medicine: Advantages and Limits or Drug treatment of Mental Health Problems: a New Framework. (2013) (0)
The 'rest of medicine' and psychiatry: why paradigms would differ reply (2013) (0)
Authors' reply (2006) (0)
Capitalism and psychiatry: applying Marxist critical theory to the mental health industry (2018) (0)

This paper list is powered by the following services:

Other Resources About Joanna Moncrieff

What Schools Are Affiliated With Joanna Moncrieff?

Joanna Moncrieff is affiliated with the following schools: